Nutrient intake and stimulant drugs in hyperactive children [Hyperkinetic syndrome]

Recent studies have demonstrated suppressed growth of height and weight in children receiving stimulant drugs for hyperactivity. For approximately twelve months, growth data and food records were collected on two subjects receiving different types and dosages of stimulant drugs. The two cases demons...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Dietetic Association 1977-04, Vol.70 (4), p.373-377
Hauptverfasser:	Lucas, B, Sells, C.J
Format:	Artikel
Sprache:	eng
Schlagworte:	Ascorbic Acid Calcium, Dietary Child Clinical Trials as Topic Dextroamphetamine - pharmacology Dextroamphetamine - therapeutic use Diet - standards Dietary Proteins Dose-Response Relationship, Drug Energy Intake Feeding and Eating Disorders Growth - drug effects Humans Hyperkinesis - drug therapy Iron Male Methylphenidate - pharmacology Methylphenidate - therapeutic use Vitamin A
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Recent studies have demonstrated suppressed growth of height and weight in children receiving stimulant drugs for hyperactivity. For approximately twelve months, growth data and food records were collected on two subjects receiving different types and dosages of stimulant drugs. The two cases demonstrated that dextroamphetamine levels of 10 mg. or more and methylphenidate levels of 30 mg. or more decreased caloric intake significantly. This decrease may be limiting for long-term growth. Both subjects had a variety of feeding problems due to poor appetite. Careful nutritional evaluation and planning are important to insure optimal energy and nutrient intake in these children receiving stimulant drugs.
ISSN:	0002-8223 1878-3570
DOI:	10.1016/S0002-8223(21)06453-1